Skip to content
OpenCapital
Get started

Haemonetics HAE Hospital — Restructuring related costs

Other segment segments

Blood Center
$0-100%
Plasma
$0-100%

Similar metrics at other companies

John Wiley & Sons, Inc. logo
WLYBRestructuring and related charges
$3.08M-75.4%
Extreme Networks logo
EXTRRestructuring And Related Charges
$0+100%
John Wiley & Sons, Inc. logo
WLYBRestructuring and related charges
$3.08M-75.4%
Benchmark Electronics logo
BHERestructuring Charges And Other Costs
$3.75M-67.2%
Gates Industrial Corporation logo
GTESRestructuring expenses
$700K-56.3%
Envista Holdings Corporation logo
NVSTRestructuring Charges
$0-100%

Other financials

Income statement

See full
Revenue$346.4M+4.8%
Gross profit$198.2M+2.7%
Operating income$67.4M+14.2%
Net income$44.7M+19.3%
EPS (diluted)$0.95+28.4%

Balance sheet

See full
Cash & equivalents$245.4M-20.0%
Total debt$1.3B-0.7%
Total equity$796.3M-3.0%
Total assets$2.4B-2.2%

Cash flow

See full
Operating cash flow$70.9M-39.1%
CapEx$17.7M+12.9%
Free cash flow$53.3M-47.2%

Valuation

See full
Market cap$3.31B-18.0%

Profitability

See full
Gross margin59%+4.0pp
Operating margin19%+5.9pp
Net margin13.3%+3.8pp
FCF margin19.5%+9.1pp

Returns & leverage

See full
Return on equity19.3%+5.2pp
Debt / equity1.6×0.0×
Current ratio3×+1.3×

Where this comes from

Reported directly by Haemonetics in its filing.

Tagged under the XBRL concept hae:RestructuringRelatedCosts.

The official record: Haemonetics’s 10-K, filed May 20, 2026, on SEC EDGAR. View the filing →

Ask your AI about Haemonetics's hospital — restructuring related costs.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Haemonetics's hospital — restructuring related costs?
Haemonetics (HAE) reported hospital — restructuring related costs of $0 in Q1 2026.
How has Haemonetics's hospital — restructuring related costs changed year-over-year?
Haemonetics's hospital — restructuring related costs decreased by 100.0% year-over-year, from $103K to $0.
What is the long-term trend for Haemonetics's hospital — restructuring related costs?
Over 4 years (2022 to 2026), Haemonetics's hospital — restructuring related costs has grown at a -100.0% compound annual growth rate (CAGR), from $379K to $0.
What does hospital — restructuring related costs mean?
Includes expenses associated with organizational changes, such as workforce reductions, facility consolidations, or process re-engineering within the hospital segment. Monitoring these costs helps investors evaluate the impact of strategic pivots on short-term profitability.